Gov. Ron DeSantis announces new Regeneron treatment site in ... - dofaq.co
Gov. Ron DeSantis announces new Regeneron treatment site in ...
WPLG Local 10 - 18 Aug 2021
Gov. Ron DeSantis announced Wednesday that the state will begin dispensing Regeneron monoclonal antibodies to those who qualify for the treatment at C.B. ...
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns
Reuters - 25 Mar 2024
Regeneron's blood cancer therapy faces setback as FDA raises trial concerns ...
FDA blocks approval of Regeneron's blood cancer drug over confirmatory trial enrollment
Fierce Biotech - 25 Mar 2024
FDA blocks approval of Regeneron's blood cancer drug over confirmatory trial enrollment ...
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Yahoo Finance - 26 Mar 2024
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA ...
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma
BioSpace - 25 Mar 2024
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma ...
Intellia ending work with Regeneron on hemophilia B gene therapy
Hemophilia News Today - 27 Mar 2024
Intellia ending work with Regeneron on hemophilia B gene therapy ...
Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more
STAT - 25 Mar 2024
Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more ...
Regeneron Pharmaceuticals Inc. stock rises Wednesday, still underperforms market
MarketWatch - 27 Mar 2024
Regeneron Pharmaceuticals Inc. stock rises Wednesday, still underperforms market ...
Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup
Yahoo Finance - 28 Mar 2024
Biotech veteran Art Krieg postpones retirement to build an unorthodox drug startup ...
Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment?
Yahoo Finance - 26 Mar 2024
Is Regeneron Pharmaceuticals (NASDAQ:REGN) A Risky Investment? ...
Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends - Regeneron Pharmaceuticals (NASDA
Benzinga - 28 Mar 2024
Behind the Scenes of Regeneron Pharmaceuticals's Latest Options Trends - Regeneron Pharmaceuticals (NASDA ...
Down to Business: Antitrust claim brought by Regeneron revived
The Daily Gazette - 27 Mar 2024
Down to Business: Antitrust claim brought by Regeneron revived ...
Regeneron hit with FDA rejection for blood cancer therapy
Pharmaceutical Technology - 26 Mar 2024
Regeneron hit with FDA rejection for blood cancer therapy ...
Yancopoulos of Regeneron works to expand Dupixent success
STAT - 21 Mar 2024
Yancopoulos of Regeneron works to expand Dupixent success ...
BCHS students win three research awards at Regeneron Science Fair
Bethlehem Central School District - 25 Mar 2024
BCHS students win three research awards at Regeneron Science Fair ...
High school seniors win $1.8 Million at Regeneron Science Talent Search 2024 for innovative scientific research on ...
Science News for Students - 12 Mar 2024
High school seniors win $1.8 Million at Regeneron Science Talent Search 2024 for innovative scientific research on ... ...
Gen Z's Search for Ethical AI at Regeneron Science Talent Search
Innovation & Tech Today - 27 Mar 2024
Gen Z's Search for Ethical AI at Regeneron Science Talent Search ...
US appeals court revives Regeneron's antitrust lawsuit against Novartis
Reuters - 18 Mar 2024
US appeals court revives Regeneron's antitrust lawsuit against Novartis ...
Pharmalittle: We're reading about a Novo Nordisk deal, a Regeneron setback, and more
STAT - 25 Mar 2024
Pharmalittle: We're reading about a Novo Nordisk deal, a Regeneron setback, and more ...
Intellia opts out of hemophilia gene editing work with Regeneron
Fierce Biotech - 22 Mar 2024
Intellia opts out of hemophilia gene editing work with Regeneron ...